Benjamin S B
Department of Medicine, Georgetown University, Washington, DC, USA.
Gastrointest Endosc Clin N Am. 1996 Apr;6(2):277-86.
Complications are a part of the practice of medicine. This is amply true for gastrointestinal endoscopy. The medications currently used in the practice of gastrointestinal endoscopy are essential to our ability to perform the wide array of diagnostic and therapeutic procedures that have become the hallmark of modern day gastroenterology. As in all of medicine, a decision is based on an assessment of risk versus benefit. Yes, these medications do carry risk with their use; however, with proper preparation and careful administration, the benefits derived far exceed the risks. We are able to perform a host of endoscopic surgical procedures precluding higher risk alternatives; patients are saved the anxiety and discomfort associated with the procedure and, in situations where follow-up procedures are necessary, they usually are more than willing to return. Maintaining these gains is the responsibility of the gastrointestinal endoscopist community and requires the recognition of the risks and a continuous effort to minimize them.
并发症是医学实践的一部分。这在胃肠内镜检查中尤为如此。目前胃肠内镜检查实践中使用的药物对于我们进行广泛的诊断和治疗程序的能力至关重要，这些程序已成为现代胃肠病学的标志。与所有医学领域一样，决策基于对风险与收益的评估。的确，这些药物在使用时确实存在风险；然而，通过适当的准备和谨慎的给药，所获得的益处远远超过风险。我们能够进行一系列内镜手术，避免了更高风险的替代方案；患者免除了与手术相关的焦虑和不适，并且在需要后续手术的情况下，他们通常非常愿意返回。维持这些成果是胃肠内镜医师群体的责任，这需要认识到风险并持续努力将其降至最低。
